Canada's Andlauer Healthcare Q2 revenue misses estimates, net income falls

Andlauer Healthcare

31/07/2025 22:42

Overview

Andlauer Q2 2025 revenue falls, missing analyst expectations

Net income declines to CAD 13.5 mln from CAD 15.7 mln yr/yr

Co to be acquired by UPS in CAD 2.2 bln all-cash deal

Outlook

Andlauer Healthcare sees ongoing challenges in US truckload businesses

Company anticipates organic growth in Canadian specialized transportation network

Result Drivers

US TRUCKLOAD CHALLENGES - Continued challenges in US-based truckload businesses contributed to revenue decline

DECONSOLIDATION IMPACT - Deconsolidation of Nova Pack led to significant drop in packaging revenue

LEGAL FEES - Increased legal and professional fees related to UPS acquisition impacted operating income

Key Details

Metric
Beat/Miss
Actual
Consensus Estimate
Q2 Revenue
Miss
C$156.60 mln
C$167.20 mln (6 Analysts)
Q2 EPS
C$0.34
Q2 Net Income
C$13.50 mln
Q2 EBITDA
C$38.10 mln
Q2 EBITDA Margin
24.3%
Q2 Operating Expenses
C$24.60 mln
Q2 Operating Income
C$18.90 mln


Analyst Coverage

The current average analyst rating on the shares is "hold" and the breakdown of recommendations is 1 "strong buy" or "buy", 2 "hold" and 1 "sell" or "strong sell"

The average consensus recommendation for the healthcare facilities & services peer group is "buy."

Wall Street's median 12-month price target for Andlauer Healthcare Group Inc is C$55.00, about 3.5% above its July 30 closing price of C$53.10

The stock recently traded at 28 times the next 12-month earnings vs. a P/E of 21 three months ago

Press Release: ID:nCNWL0QKfa

(This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)